Taha A A, Elsheikh H A, Khalafalla A E, Osman I A, Abdullah A S
Department of Medicine, Faculty of Veterinary Science, University of Khartoum, Khartoum North, Sudan.
Vet J. 1999 Nov;158(3):210-5. doi: 10.1053/tvjl.1999.0374.
The pharmacokinetic behaviour of tylosin was compared in five Desert sheep and five Nubian goats. The animals were given a single dose of 20% tylosin (15 mg/kg), either intravenously (i.v.) or intramuscularly (i.m.). Following i.v. administration, the volumes of distribution and the elimination half-life times were similar in both species, whereas in goats a greater volume of the central compartment and faster clearance were observed. For the i.m. route, similar pharmacokinetics were observed in both species. The bioavailability (f) of the drug in goats (0.84 +/- 0.11) was not significantly higher than that in sheep (0.73 +/- 0.08). The present study has shown that, despite the significant differences in some of the drug pharmacokinetic parameters between sheep and goats for the i.v. route, identical intravenous and intramuscular dosage regimens of tylosin may be recommended for the two species.
在五只荒漠绵羊和五只努比亚山羊中比较了泰乐菌素的药代动力学行为。给动物静脉注射(i.v.)或肌肉注射(i.m.)单剂量20%泰乐菌素(15mg/kg)。静脉给药后,两种动物的分布容积和消除半衰期相似,而山羊的中央室容积更大,清除更快。对于肌肉注射途径,两种动物观察到相似的药代动力学。该药物在山羊中的生物利用度(f)为0.84±0.11,并不显著高于绵羊(0.73±0.08)。本研究表明,尽管绵羊和山羊在静脉注射途径的某些药物药代动力学参数上存在显著差异,但对于这两个物种,可推荐相同的泰乐菌素静脉和肌肉注射给药方案。